Michael R. Minogue - 06 Aug 2021 Form 4 Insider Report for ABIOMED INC

Role
Chairman, President, CEO, Director
Signature
/s/ Marc A Began (by power of attorney)
Issuer symbol
N/A
Transactions as of
06 Aug 2021
Net transactions value
-$10,298,390
Form type
4
Filing time
10 Aug 2021, 17:07:18 UTC
Previous filing
06 Aug 2021
Next filing
25 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock $.01 par value Options Exercise $566,504 +24,471 +12% $23.15 236,106 06 Aug 2021 Direct F5
transaction ABMD Common Stock $.01 par value Sale $8,564,850 -24,471 -10% $350.00 211,635 06 Aug 2021 Direct F6, F7
transaction ABMD Common Stock $.01 par value Options Exercise $162,907 +7,037 +3.3% $23.15 218,672 09 Aug 2021 Direct F5
transaction ABMD Common Stock $.01 par value Sale $2,462,950 -7,037 -3.2% $350.00 211,635 09 Aug 2021 Direct F6, F7
holding ABMD Common Stock $.01 par value 52,555 06 Aug 2021 By Trust - A
holding ABMD Common Stock $.01 par value 73,745 06 Aug 2021 By Trust - B
holding ABMD Common Stock $.01 par value 32,810 06 Aug 2021 By Trust - C
holding ABMD Common Stock $.01 par value 655 06 Aug 2021 By Trust - D
holding ABMD Common Stock $.01 par value 38,560 06 Aug 2021 By Trust - E
holding ABMD Common Stock $.01 par value 85,040 06 Aug 2021 By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABMD Stock Option (Right to Buy) Disposed to Issuer $0 -31,508 -90% $0.000000 3,492 06 Aug 2021 Common stock 31,508 $23.15 Direct F1, F2, F5, F8
holding ABMD Stock Option (right to buy) 85,000 06 Aug 2021 Common Stock 0 $21.55 Direct F2, F3
holding ABMD Stock Option (right to buy) 35,000 06 Aug 2021 Common Stock 0 $66.25 Direct F2, F3
holding ABMD Stock Option (right to buy) 30,500 06 Aug 2021 Common Stock 0 $99.62 Direct F3, F4
holding ABMD Stock Option (right to buy) 33,000 06 Aug 2021 Common Stock 0 $134.51 Direct F3, F4
holding ABMD Stock Option (right to buy) 30,000 06 Aug 2021 Common Stock 0 $381.97 Direct F3, F4
holding ABMD Stock Option (right to buy) 50,000 06 Aug 2021 Common Stock 0 $266.39 Direct F3, F4
holding ABMD Stock Option (Right to Buy) 20,898 06 Aug 2021 Common Stock 0 $223.90 Direct F3, F4
holding ABMD Stock Option (Right to Buy) 30,000 06 Aug 2021 Common Stock 0 $283.88 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F5 Exercise of stock options pursuant to reporting owners 10b5-1 plan.
F6 Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F7 This price represents the sale price of the transactions on the reported date at $350.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8 The exercise of stock options pursuant to the reporting owners 10b5-1 plan occurred over multiple dates. This date represents the earliest exercise reported on this Form. Please refer to Table I for the each of the reported exercise dates.